<DOC>
	<DOCNO>NCT01616589</DOCNO>
	<brief_summary>The purpose research determine saliva sample use alternate sample type test fragile X . By use saliva instead blood , would easier patient fragile X testing .</brief_summary>
	<brief_title>Validation Saliva Esoterix Genetic Laboratories Fragile X Assay</brief_title>
	<detailed_description>Saliva sample prospectively collected subject previously test Esoterix Genetic Laboratories , LLC use blood specimen diagnose fragile X intermediate , premutations ( carrier ) full mutation ( affect ) . Results fragile X test saliva compare result blood sample previously submit Esoterix Genetic Laboratories test . Data study use regulatory submission .</detailed_description>
	<mesh_term>Fragile X Syndrome</mesh_term>
	<criteria>Subject previously identify molecular test Esoterix Genetic Laboratories Fragile X intermediate , premutation ( carrier ) full mutation ( affect ) . In opinion subject 's physician , subject medically stable able provide require quantity saliva . If Subject least 18 year age : Subject must willing give write informed consent Subject must willing comply collection procedure If Subject 18 year age , legally authorize representative must give write informed consent agree comply study procedure . Subject determine individual normal FMR1 gene . Subject know medical condition would cause risk donor , relevant , fetus result saliva collection .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Fragile X syndrome</keyword>
	<keyword>Fragile X full mutation</keyword>
	<keyword>Fragile X premutation</keyword>
	<keyword>Fragile X intermediate</keyword>
	<keyword>CGG repeat length</keyword>
</DOC>